Back/Neogenomics Highlights BTL's EMSCULPT NEO in Astronaut Training for Space Missions
tech·October 20, 2025·neo

Neogenomics Highlights BTL's EMSCULPT NEO in Astronaut Training for Space Missions

ED
Editorial
Cashu Finance·2 min read
TL;DR
  • BTL's EMSCULPT NEO aids astronaut Tibor Kapu's muscle conditioning for the ISS mission, preventing significant muscle loss in space.
  • Medical tests show EMSCULPT NEO improves muscle hypertrophy, body composition, and cardiopulmonary fitness for astronauts' optimal health.
  • BTL's technology is versatile, benefiting athletes and patients, and proves effective in enhancing health outcomes across various settings.

Innovative Muscle Conditioning for Space Missions: BTL's EMSCULPT NEO

BTL, a leader in medical technologies, makes headlines with its EMSCULPT NEO device, which plays an integral role in the pre-flight training of Hungarian research astronaut Tibor Kapu for his upcoming mission to the International Space Station (ISS). This collaboration forms part of the HUNOR (Hungarian To Orbit) program, emphasizing the importance of effective muscle conditioning for astronauts who face the significant challenge of potential muscle mass loss—up to 30%—during their time in space. The use of EMSCULPT NEO in this rigorous training regimen highlights the device's capabilities beyond traditional applications, demonstrating its effectiveness in extreme conditions.

Dr. Nóra Sydó, a cardiologist and sports medicine expert leading the astronaut training at Semmelweis University, underscores the device's efficacy. Medical tests reveal impressive results, including muscle hypertrophy, improved body composition, and enhanced cardiopulmonary fitness, which are crucial for astronauts who must maintain optimal physical condition in the weightlessness of space. EMSCULPT NEO is integrated into a comprehensive training protocol aimed at boosting endurance, strength, balance, and recovery, yielding superior outcomes compared to conventional training methods. This innovative approach not only prepares Kapu for the rigors of space travel but also showcases the versatility of BTL's technology.

Tomas Schwarz, CEO of BTL Enterprise Group, expresses pride in the contributions of EMSCULPT NEO to astronaut training, noting the broader implications of their innovations for diverse populations. The device is designed for various applications, including use by athletes and patients experiencing muscle loss, reinforcing BTL's commitment to advancing medical technologies that enhance quality of life. This partnership with the HUNOR program exemplifies how advanced medical solutions can meet the unique challenges of extreme environments, further establishing BTL as a pioneer in the field.

In addition to its role in space training, BTL's EMSCULPT NEO reflects the company's dedication to improving health outcomes through innovation. The technology is already widely adopted in thousands of medical practices across aesthetics and functional medicine, proving its versatility and efficacy. As BTL continues to push the boundaries of medical technology, the success of EMSCULPT NEO in preparing astronauts is a notable achievement that underscores the potential of these advancements in various settings.